Senior Director, Business Development

Flagship Pioneering; Cambridge (MA); On-site; USD 217,000 - 275,000; Full time

Job summary

Quotient Therapeutics is seeking a Senior Director of Business Development to lead partnering, asset in-licensing, and market intelligence, reporting to the CFO. The role shapes the portfolio and executes partnerships with external entities.

The candidate will blend scientific insight with commercial judgment, manage end-to-end deals, and collaborate across R&D, clinical, regulatory, and executive teams in a fast-paced, early-stage setting.

Qualifications

• Advanced degree in life sciences, medicine, business, or related field; MBA or equivalent is a plus.
• 10+ years of biotech/pharma business development, corporate strategy, licensing, or related function.
• Proven experience executing or contributing to biopharma partnership and licensing transactions.
• Strong understanding of drug development and biopharma industry.
• Experience evaluating external assets and cross-functional diligence.
• Ability to perform market, competitive, and commercial analyses for drug programs.
• Strong financial/analytical capabilities incl. asset valuation and deal economics.
• Excellent negotiation, communication, and presentation skills.
• Entrepreneurial mindset and willingness to work hands-on in early-stage environment.

Responsibilities

• Develop and execute a comprehensive business development strategy aligned with scientific, clinical, and corporate objectives.
• Identify, evaluate, and cultivate relationships with potential pharma and biotech partners.
• Lead partnership opportunities from identification through valuation, negotiation, and execution.
• Develop partnership materials including assessments, rationales, valuations, and exec presentations.
• Build and maintain a network across biotech and pharma industries.
• Identify opportunities for co-development, licensing, and other strategic transactions.
• Support corporate strategy by providing external market and competitive intelligence.
• Lead evaluation of external assets and technologies to expand the pipeline.
• Establish processes for sourcing and prioritizing in-licensing opportunities.
• Coordinate cross-functional due diligence with scientific, regulatory, IP, legal, and finance teams.
• Develop business cases and recommendations for external program investments.
• Lead licensing negotiations around economics, development responsibilities, milestones, royalties, territories, governance.
• Maintain a forward-looking view of emerging technologies and platform opportunities.

Skills

Strategic partnerships

Negotiation

Cross-functional collaboration

Business development

Relationship building

Education

Advanced degree in life sciences/medicine/business

Job description

Quotient is seeking an entrepreneurial, highly strategic Senior Director of Business Development to lead the company's partnering, asset in-licensing, and market intelligence activities. Reporting to the CFO, this individual will play a critical role in shaping the company's portfolio and business strategy, identifying external opportunities, and executing partnerships that create significant value for the company and its stakeholders.

The ideal candidate combines strong scientific and commercial judgment with demonstrated transaction leadership and the ability to operate effectively in an early-stage, fast-paced, resource-constrained environment. This person will be equally comfortable evaluating an external asset, developing a market landscape, engaging with potential partners, and working cross-functionally with R&D, clinical, regulatory, and executive leadership.

We are looking for someone with a proven track record in Business Development within the biotech or pharmaceutical sectors with significant experience leading collaboration and in-licensing deals and demonstrated strategic thinking and relationship building experience. On a personal level, Quotients enjoy a fast-paced environment, think like entrepreneurs, are adaptable, accountable, work proactively and look out for each other.

Responsibilities

• Develop and execute a comprehensive business development strategy aligned with the company's scientific, clinical, and corporate objectives
• Identify, evaluate, and cultivate relationships with potential pharmaceutical, biotechnology, academic, and other strategic partners
• Lead commercial partnership opportunities from initial identification and diligence through valuation, negotiation, deal structuring, and execution
• Develop compelling partnership materials, including opportunity assessments, strategic rationales, valuation analyses, and executive presentations
• Build and maintain a strong network across the biotechnology and pharmaceutical industries
• Identify opportunities for co-development, licensing, collaborations, research partnerships, and other strategic transactions
• Support corporate strategy and financing activities by providing external market and competitive intelligence
• Lead identification and evaluation of external assets and technologies that could complement or expand the company's internal pipeline
• Establish systematic processes for sourcing and prioritizing in-licensing opportunities
• Coordinate cross-functional diligence with scientific, clinical, regulatory, IP, legal, and finance teams
• Develop business cases and recommendations for investment in external programs
• Lead negotiations around licensing economics, development responsibilities, milestones, royalties, territories, governance, and other key deal terms
• Maintain a forward-looking view of emerging technologies, mechanisms, therapeutic approaches, and platform opportunities relevant to the company's strategy

Qualifications

• Advanced degree in life sciences, medicine, business, or a related field; MBA or equivalent business training is a plus
• 10+ years of relevant experience in biotechnology or pharmaceutical business development, corporate strategy, licensing, or a related function
• Demonstrated experience executing or materially contributing to biopharma partnership and licensing transactions
• Strong understanding of drug development and the biotechnology/pharmaceutical industry
• Experience evaluating external therapeutic assets and conducting cross-functional diligence
• Demonstrated ability to perform or oversee market, competitive, and commercial analyses for drug development programs
• Strong financial and analytical capabilities, including familiarity with asset valuation, deal economics, forecasting, and scenario analysis
• Excellent negotiation, communication, and presentation skills
• Strong scientific and strategic judgment, with the ability to rapidly assess complex information and make clear recommendations
• Ability to build trusted relationships with senior executives and external partners across the biopharma ecosystem
• Entrepreneurial mindset and willingness to work hands-on in an early-stage environment

Values and Behaviors

• Encourage respectful disagreement and cultivate open-minded, ego-free interactions to continuously push each other towards excellence
• Seek out diverse perspectives; practice active listening and genuine curiosity to ensure all contributions are valued, regardless of source
• Recognize the impact of your behavior, language and attitudes, and strive for balanced, meaningful exchanges that enhance mutual growth and understanding in all interactions
• Use a company-first mindset to guide decision-making; prioritize team over individual success
• Take calculated risks and challenge convention in the quest for exceptional outcomes

About Quotient

Quotient Therapeutics is a privately-held, early stage company developing breakthrough medicines informed by natural somatic genetic diversity present in patients. Through our work in somatic genomics, we are forging a new status quo for biopharma research and development across a broad pipeline of internal and partnered programs.

The company was founded by Flagship Pioneering, an innovative enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Generate Biomedicines, Sana Biotechnology (SANA), Tessera Therapeutics, Evelo Biosciences (EVLO), Indigo Agriculture, Seres Therapeutics (MCRB), and Syros Pharmaceuticals (SYRS).

Quotient Therapeutics and Flagship Pioneering are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Privacy Notice for Applicants

When you apply for a role at Flagship Pioneering or one of its portfolio companies, we collect and use personal information you provide (such as your name, contact details, work history, and application materials) to evaluate your application, communicate with you, and comply with legal obligations. Your application data is processed through Greenhouse, our applicant tracking system, and may also be reviewed using AI-assisted screening tools. We do not sell your personal information. California residents have rights under the CCPA/CPRA including to know, delete, and opt out of the sharing of their personal information. If you are located in the EU or UK, we process your data under GDPR and you have rights to access, rectify, and erase your data. To exercise your rights or for questions, contact [e-mail].

The salary range for this role is $217,000 - $275,000. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Quotient Therapeutics, Inc. currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on Quotient Therapeutics, Inc.'s good faith estimate as of the date of publication and may be modified in the future.